SEARCH

SEARCH BY CITATION

References

  • 1
    Favus MJ, Coe FL. Clinical characteristics and pathogenetic mechanisms in hyperuricosuric calcium oxalate renal stones disease. Scand. J. Urol. Nephrol. Suppl. 1980; 53: 1717.
  • 2
    Sorensen CM, Chandhoke PS. Hyperuricosuric calcium nephrolithiasis. Endocrinol. Metab. Clin. North Am. 2002; 31: 91525.
  • 3
    Koide T. Hyperuricosuria and urolithiasis. Nippon Rinsho 1996; 54: 32736.
  • 4
    Brien G, Bick C. Allopurinol in the recurrence prevention of calcium oxalate lithiasis. Eur. Urol. 1977; 3: 356.
  • 5
    Petit C. Calcium lithiasis: uric acid under question. Nephrologie 1984; 5: 1924. (In French.)
  • 6
    Hofbauer J, Zechner O. Impact of allopurinol treatment on the prevention of hyperuricosuric calcium oxalate lithiasis. Eur. Urol. 1988; 15: 2279.
  • 7
    Meyer JL, Bergert JH, Smith LH. The epitaxially induced crystal growth of calcium oxalate by crystalline uric acid. Invest. Urol. 1976; 14: 11519.
  • 8
    Grases F, Costa-Bauzá A, March JG, Masarova L. Glycosaminoglycans, uric acid and calcium oxalate urolithiasis. Urol. Res. 1991; 19: 37580.
  • 9
    Grases F, Costa-Bauzá A, Ramis M, Montesinos V, Conte A. Simple classification of renal calculi closely related to their micromorphology and etiology. Clin. Chim. Acta 2002; 322: 2936.
  • 10
    Grases F, García-Ferragut L, Costa-Bauzá A. Analytical study of renal calculi. A new insight. Recent Res. Dev. Pure Appl. Anal. Chem. 1998; 1: 187206.
  • 11
    Perelló J, Sanchis P, Grases F. Determination of uric acid in urine, saliva and calcium oxalate renal calculi by high-performance liquid chromatography/mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2005; 824: 17580.
  • 12
    Grases F, Costa-Bauzá A, García-Ferragut L. Biopathological crystallization: a general view about the mechanisms of renal stone formation. Adv. Colloid Interface Sci. 1998; 74: 16994.